| Announce Date | 10/28/2025 |
| EPS Normalized Actual | $99.5 (Beat by $3.65) |
| EPS GAAP Actual | $99.5 (Beat by $3.65) |
| Revenue Actual | $9.008B |
| Revenue Surprise | Beat by $9008M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $17.25919 |
| EPS GAAP Estimate | $17.25919 |
| Revenue Estimate | $4.968582089B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 373.0025 | 11.48 | 360.53001 | 389.73066 | 4 |
| Dec 2028 | 290.7 | 14.73 | 285.63667 | 303.16788 | 6 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 84.86 | 37.97559 | 9.008B | 11.26% | 2792.78M |
| FQ2 2025 (Jun 2025) | 27.54 | -21.15579 | 6.798B | 13.81% | 507.99M |
| FQ1 2025 (Mar 2025) | 10.14 | 10.14 | 4.762B | 7.29% | 4762M |
| FQ4 2024 (Dec 2024) | 32.31 | 32.31 | 5.471B | 12.56% | 5471M |
| FQ3 2024 (Sep 2024) | 75.36 | 75.36 | 7.994B | 8.17% | 7994M |
| FQ2 2024 (Jun 2024) | 44.95 | 44.95 | 5.859B | 6.78% | 5859M |
| FQ1 2024 (Mar 2024) | 22.69 | 22.69 | 4.415B | 14.43% | 4415M |
| FQ4 2023 (Dec 2023) | 6.3 | 6.3 | 4.784B | 15.36% | 4784M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
17.25919
Consensus Revenue Estimates
4.968582089B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 65.29056 | -- | 63.91521 | 67.92169 | 11 |
| FQ3 2027 (Sep 2027) | 127.35466 | -- | 121.86046 | 133.60898 | 5 |
| FQ2 2027 (Jun 2027) | 69.34906 | -- | 66.35728 | 72.75475 | 5 |
| FQ1 2027 (Mar 2027) | 29.38747 | -- | 28.11967 | 30.83067 | 5 |
| FQ4 2026 (Oct 2026) | 108.83305 | -- | 105.5537 | 111.89505 | 9 |
| FQ3 2026 (Jul 2026) | 52.90141 | -60.41 | 51.30739 | 54.38978 | 9 |
| FQ2 2026 (Jun 2026) | 58.55268 | 52.97 | 52.61618 | 60.6966 | 11 |
| FQ1 2026 (Mar 2026) | 17.25919 | 41.25 | 15.50933 | 17.89114 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 7.3B | -- | 7.18B | 7.53B | 14 |
| FQ3 2027 (Sep 2027) | 10.24B | -- | 9.9B | 10.63B | 11 |
| FQ2 2027 (Jun 2027) | 7.7B | -- | 7.45B | 7.99B | 8 |
| FQ1 2027 (Mar 2027) | 5.54B | -- | 5.35B | 5.75B | 8 |
| FQ4 2026 (Oct 2026) | 9.22B | -- | 9.01B | 9.42B | 9 |
| FQ3 2026 (Jul 2026) | 6.77B | -32.98 | 6.62B | 6.92B | 10 |
| FQ2 2026 (Jun 2026) | 6.86B | 0.87 | 6.32B | 7.05B | 10 |
| FQ1 2026 (Mar 2026) | 4.97B | 4.16 | 4.58B | 5.11B | 16 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 46.88441 | 84.86 | 37.97559 | 44.75% |
| FQ2 2025 (Jun 2025) | 48.69579 | 27.54 | -21.15579 | -76.82% |
| FQ1 2025 (Mar 2025) | 10.14 | 10.14 | 100% | |
| FQ4 2024 (Dec 2024) | 32.31 | 32.31 | 100% | |
| FQ3 2024 (Sep 2024) | 75.36 | 75.36 | 100% | |
| FQ2 2024 (Jun 2024) | 44.95 | 44.95 | 100% | |
| FQ1 2024 (Mar 2024) | 22.69 | 22.69 | 100% | |
| FQ4 2023 (Dec 2023) | 6.3 | 6.3 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $6.22B | $9.01B | $2792.78M | 31% |
| FQ2 2025 (Jun 2025) | $6.29B | $6.8B | $507.99M | 7.47% |
| FQ1 2025 (Mar 2025) | $0B | $4.76B | $4762M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $5.47B | $5471M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $7.99B | $7994M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $5.86B | $5859M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $4.42B | $4415M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $4.78B | $4784M | 100% |